title: Improving risk assessment.
abstract: Widespread sharing and analysis of clinical trial data and a U.S. government initiative to engineer nonclinical cell-based models that mimic human biological processes have the potential to      improve predictions of drug-related adverse events.
authors.affiliation: Safety Assessment, Development Sciences, Genentech, South San Francisco, CA 94080, USA.
authors.forename: Donna M
authors.initials: DM
authors.lastname: Dambach
authors.forename: Hirdesh
authors.initials: H
authors.lastname: Uppal
mesh_terms: D002986:Clinical Trials as Topic; D003299:Cooperative Behavior; D006801:Humans; D056656:Lab-On-A-Chip Devices / Q000592:standards; D008954:Models, Biological; D018570:Risk Assessment / Q000592:standards*